Early phase drug discovery research requires the highest level of accurate and reproducible testing in order to give you the proof to move confidently forward
Researchers have identified a molecular signature in patients who responded to amlexanox, an anti-inflammatory and anti-allergic drug used to treat asthma that was developed in the 1980s in Japan